Skip to content

CervoMed Inc.

CRVO

CIK 0001053691 · Pharmaceutical Preparations · Nasdaq

  • Diffusion Pharmaceuticals Inc. (until 2023-08-14)
  • RestorGenex Corp (until 2016-01-14)
  • Stratus Media Group, Inc (until 2014-03-07)
  • FERIS INTERNATIONAL, INC. (until 2008-07-16)
  • TITAN MOTORCYCLE CO OF AMERICA INC (until 2008-02-22)
← back to feed
Revenue (TTM)
$4M
−58.9% YoY Q1 May 2026
Net Income (TTM)
−$26.84M
−65.5% YoY Q1 May 2026
EPS Diluted (TTM)
$101,903,976.05
+4.7% YoY Q1 May 2026
Gross Margin
5.4%
Q1 May 2026
Operating Margin
-702.2%
Q1 May 2026
Net Margin
-671.5%
Q1 May 2026
Free Cash Flow (TTM)
−$15.27M
Q1 May 2026
Cash
$7.94M
Q1 May 2026
Total Debt
$50K
Q1 May 2026
Shares Outstanding
9.26M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings